journal article·2020-11-24

Prediction of Cancer Stem Cell Fate by Surface-Enhanced Raman Scattering Functionalized Nanoprobes

Rupa Haldavnekar, Sivaprasad Chinnakkannu Vijayakumar, Krishnan Venkatakrishnan, Bo Tan

ACS Nano· Volume 14· Issue 11
Publisher page

Abstract

Cancer stem cells (CSCs) are the fundamental building blocks of cancer dissemination, so it is desirable to develop a technique to predict the behavior of CSCs during tumor initiation and relapse. It will provide a powerful tool for pathological prognosis. Currently, there exists no method of such prediction. Here, we introduce nickel-based functionalized nanoprobe facilitated surface enhanced Raman scattering (SERS) for prediction of cancer dissemination by undertaking CSC-based surveillance. SERS profiling of CSCs of various cell lines (breast cancer, cervical cancer, and lung cancer) was compared with their cancer counterparts for the prediction of prognosis, with statistical significance of single-cell sensitivity. The single-cell sensitivity is critical as even a few CSCs are capable of initiating a tumor. Intermediate states of CSC transmutation to cancer cells and its reverse were monitored, and nanoprobe-assisted SERS profiling was undertaken. We experimentally demonstrated that the quasi-intermediate CSC states have dissimilar profiles during the transformation from cancer to CSC and vice versa enabling statistical differentiation without ambiguity. It was also observed that molecular signatures of these opposite pathways are cancer-type specific. This observation provided additional clarity to the current understanding of relatively unfamiliar quasi-intermediate states; making it possible to predict CSC dissemination for variety of cancers with ∼99% accuracy. Nano probe-based prediction of CSC fate is a powerful prediction tool for ultrasensitive prognosis of malignancy in a complex environment. Such CSC-based cancer prognosis has never been proposed before. This prediction technique has potential to provide insights for cancer diagnosis and prognosis as well as for obtaining information instrumental in designing of meaningful CSC-based cancer therapeutics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Spectroscopy Techniques in Biomedical and Chemical Research · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Biomedical Engineering, Science and Technology (iBEST), Li Ka-Shing Knowledge Institute, 209 Victoria Street, Toronto, ON, Canada M5B 1T8

Ultrashort Laser Nanomanufacturing Research Facility, Department of Mechanical and Industrial Engineering, Ryerson University, 350 Victoria Street, Toronto, ON, Canada M5B 2K3

BioNanoInterface Facility, Department of Mechanical and Industrial Engineering, Ryerson University, 350 Victoria Street, Toronto, ON, Canada M5B 2K3

Nanocharacterization Laboratory, Department of Aerospace Engineering, Ryerson University, 350 Victoria Street, Toronto, ON, Canada M5B 2K3

Department of Biomedical Engineering, Ryerson University, 350 Victoria Street, Toronto, ON, Canada M5B 2K3

Keenan Research Center for Biomedical Science, St. Michael’s Hospital, 30 Bond Street, Toronto, ON, Canada M5B 1W8

Funding

Government of Canada

References (100+)

Show source-provided references
1. 10.1038/nature0794310.1038/nature07943 ↗
2. 10.1038/nnano.2007.39710.1038/nnano.2007.397 ↗
3. 10.1038/nnano.2009.00410.1038/nnano.2009.004 ↗
4. 10.1038/nnano.2011.14710.1038/nnano.2011.147 ↗
5. 10.1038/nnano.2012.16710.1038/nnano.2012.167 ↗
6. 10.1038/nnano.2014.25010.1038/nnano.2014.250 ↗
7. 10.1142/S233954781830002010.1142/S2339547818300020 ↗
8. 10.1038/sj.cr.731011810.1038/sj.cr.7310118 ↗
9. 10.1186/2001-1326-2-310.1186/2001-1326-2-3 ↗
10. 10.1038/3510216710.1038/35102167 ↗
11. 10.1517/14712598.2010.48518610.1517/14712598.2010.485186 ↗
12. 10.5812/jhgg.6525310.5812/jhgg.65253 ↗
13. 10.1371/journal.pone.007979810.1371/journal.pone.0079798 ↗
14. 10.1038/s41598-019-56377-z10.1038/s41598-019-56377-z ↗
15. 10.1002/adfm.20190757210.1002/adfm.201907572 ↗
16. 10.1186/s12885-016-2774-310.1186/s12885-016-2774-3 ↗
17. 10.1016/j.drudis.2016.03.00410.1016/j.drudis.2016.03.004 ↗
18. 10.1038/nature0648910.1038/nature06489 ↗
19. 10.1038/ncb271710.1038/ncb2717 ↗
20. 10.1016/j.radonc.2013.03.02710.1016/j.radonc.2013.03.027 ↗
21. 10.1073/pnas.053029110010.1073/pnas.0530291100 ↗
22. 10.1038/nature0312810.1038/nature03128 ↗
23. 10.1016/j.semcancer.2017.03.00310.1016/j.semcancer.2017.03.003 ↗
24. 10.1155/2012/97138010.1155/2012/971380 ↗
25. 10.1002/ange.20191337510.1002/ange.201913375 ↗
26. Chapelle M. L. de la · 201910.1201/9780429458750 ↗
27. 10.1186/1752-153X-7-3710.1186/1752-153X-7-37 ↗
28. 10.1038/s41467-018-05237-x10.1038/s41467-018-05237-x ↗
29. 10.1039/C4TB01195C10.1039/C4TB01195C ↗
30. 10.1016/j.bios.2014.05.01310.1016/j.bios.2014.05.013 ↗
31. Agnieszka K. · J. Chem. Eng. · 2013 · 7 · 972
32. 10.1021/acsami.5b0227610.1021/acsami.5b02276 ↗
33. 10.1021/acsami.6b0720510.1021/acsami.6b07205 ↗
34. 10.1021/acsbiomaterials.7b0082510.1021/acsbiomaterials.7b00825 ↗
35. 10.1039/C9AY00646J10.1039/C9AY00646J ↗
36. 10.1021/acsami.9b1715010.1021/acsami.9b17150 ↗
37. 10.1038/s41580-020-0237-910.1038/s41580-020-0237-9 ↗
38. 10.1038/srep1966310.1038/srep19663 ↗
39. 10.1002/adma.20160658610.1002/adma.201606586 ↗
40. 10.1007/s00339-004-2933-210.1007/s00339-004-2933-2 ↗
41. 10.1186/1556-276X-7-40410.1186/1556-276X-7-404 ↗
42. 10.1364/OE.17.00106410.1364/OE.17.001064 ↗
43. 10.1089/biores.2012.025410.1089/biores.2012.0254 ↗
44. 10.1039/C4RA11083H10.1039/C4RA11083H ↗
45. 10.1016/j.jallcom.2012.07.02110.1016/j.jallcom.2012.07.021 ↗
46. 10.1166/asem.2016.186610.1166/asem.2016.1866 ↗
47. 10.1021/ja110964d10.1021/ja110964d ↗
48. 10.1016/j.molstruc.2012.10.06610.1016/j.molstruc.2012.10.066 ↗
49. 10.1038/srep2695210.1038/srep26952 ↗
50. 10.1021/jp310193a10.1021/jp310193a ↗
51. 10.1016/S0022-0728(77)80224-610.1016/S0022-0728(77)80224-6 ↗
52. 10.1063/1.43643610.1063/1.436436 ↗
53. 10.1021/acs.jpcc.5b0929410.1021/acs.jpcc.5b09294 ↗
54. Kosuda K. M. · 2011 · 1 · 26310.1016/B978-0-12-374396-1.00110-0 ↗
55. Machado, T. N.; Nadas, R. B.; Thaler, J.; Feitosa, L. F.; Góes, R. E. de; Kamikawachi, R. C.; Lenz, J. A.; Schreiner, W. H.; Bezerra, A. G. Plasmonics and SERS Activity: Beyond Gold and Silver; SBFoton IOPC; Sao Paulo, Brazil, 2019; pp 1–5.10.1109/SBFoton-IOPC.2019.8910175 ↗
56. 10.1021/jp060173w10.1021/jp060173w ↗
57. 10.1021/jp900958n10.1021/jp900958n ↗
58. 10.1021/acs.nanolett.7b0405210.1021/acs.nanolett.7b04052 ↗
59. 10.1002/smll.20170327410.1002/smll.201703274 ↗
60. 10.1002/adma.20160479710.1002/adma.201604797 ↗
61. 10.4236/jmp.2011.21014710.4236/jmp.2011.210147 ↗
62. 10.1021/ja401666p10.1021/ja401666p ↗
63. 10.1186/s12885-018-5169-910.1186/s12885-018-5169-9 ↗
64. 10.3399/bjgp19X70078110.3399/bjgp19X700781 ↗
65. 10.1038/s41598-020-61701-z10.1038/s41598-020-61701-z ↗
66. 10.1016/0014-4827(84)90658-X10.1016/0014-4827(84)90658-X ↗
67. 10.1021/es051043o10.1021/es051043o ↗
68. 10.1088/0957-4484/21/35/35510210.1088/0957-4484/21/35/355102 ↗
69. 10.1021/nn102055s10.1021/nn102055s ↗
70. 10.1038/nbt137710.1038/nbt1377 ↗
71. 10.1038/nnano.2011.5810.1038/nnano.2011.58 ↗
72. 10.1186/s11671-017-1853-y10.1186/s11671-017-1853-y ↗
73. Souza, T. G. F.; Ciminelli, V. S. T.; Mohallem, N. D. S. A Comparison of TEM and DLS Methods to Characterize Size Distribution of Ceramic Nanoparticles. In Journal of Physics: Conference Series; Bento Gonçalves, RS, Brazil, 2016; Vol. 733, pp 6–11.10.1088/1742-6596/733/1/012039 ↗
74. 10.1016/S0092-8674(00)81683-910.1016/S0092-8674(00)81683-9 ↗
75. 10.1016/j.devcel.2015.10.00210.1016/j.devcel.2015.10.002 ↗
76. 10.1016/j.procbio.2019.05.02710.1016/j.procbio.2019.05.027 ↗
77. 10.1021/nl302758610.1021/nl3027586 ↗
78. 10.1021/jacs.6b0878710.1021/jacs.6b08787 ↗
79. 10.1016/j.bpj.2010.06.06910.1016/j.bpj.2010.06.069 ↗
80. 10.1038/srep2332810.1038/srep23328 ↗
81. Reddel R. R. · Cancer Res. · 1985 · 45 · 1525
82. Ra M. · Cancer Res. · 1976 · 36 · 2317
83. 10.1038/s41467-017-00196-110.1038/s41467-017-00196-1 ↗
84. 10.1080/0570492070155153010.1080/05704920701551530 ↗
85. 10.1080/05704928.2014.92390210.1080/05704928.2014.923902 ↗
86. 10.18632/oncotarget.1155310.18632/oncotarget.11553 ↗
87. 10.1016/j.vibspec.2008.11.00310.1016/j.vibspec.2008.11.003 ↗
88. 10.1016/j.gene.2018.09.05210.1016/j.gene.2018.09.052 ↗
89. 10.1039/C4AY00571F10.1039/C4AY00571F ↗
90. 10.1007/s00216-009-2702-310.1007/s00216-009-2702-3 ↗
91. 10.1111/j.1365-2613.2010.00747.x10.1111/j.1365-2613.2010.00747.x ↗
92. 10.1016/j.cell.2016.06.02810.1016/j.cell.2016.06.028 ↗
93. 10.1016/j.cell.2016.11.03710.1016/j.cell.2016.11.037 ↗
94. 10.1016/j.stem.2010.04.01510.1016/j.stem.2010.04.015 ↗
95. 10.1007/s12015-016-9664-610.1007/s12015-016-9664-6 ↗
96. 10.1038/cddis.2013.40710.1038/cddis.2013.407 ↗
97. 10.1038/s41389-019-0125-310.1038/s41389-019-0125-3 ↗
98. 10.1002/jcp.2774010.1002/jcp.27740 ↗
99. 10.18632/oncotarget.403710.18632/oncotarget.4037 ↗
100. Bao B. · 2019 · 1152 · 31110.1007/978-3-030-20301-6_17 ↗